Skip to main content

Detect Respiratory Impairment Severity

High accuracy, non-invasive test to support early detection and management decisions in respiratory distress to failure

presentation-1

 

Fast

Actionable results in under 2 minutes

target

 

Accurate

Precision with near 1:1 relationship with arterial blood gas

head

 

Painless

Non-invasive measurements conducted by any qualified medical staff

Faster Diagnostic Clarity. Streamlined Workflow.

Today’s frontline clinicians face increasing diagnostic uncertainty when evaluating patients with respiratory distress. Cardiovascular and respiratory abnormalities often overlap with vague symptoms, prompting numerous serial tests to rule out conditions and leading to unnecessary observation admissions.

Built for the rapid evaluation of your patient's cardiorespiratory function, the AGM100® closes critical gaps in the detection of hypoxemic severity and gas exchange abnormality to improve patient safety, support diagnosis and treatment to accelerate healthcare decision making. 

Patient Symptoms

  • Chest pain
  • Dyspnea
  • Undifferentiated

Conditions Associated with Respiratory Impairment

  • COPD exacerbation
  • Pneumonia
  • Heart failure
  • Pulmonary embolism
  • Acute asthma
  • Respiratory distress and failure 

Challenges in Emergency Care

  • Multiple serial tests - about 8 per ED patient1
  • 30% of cardiorespiratory patient visits result in observation or short stay (<24 hours)
  • High variability and misclassification risk in current respiratory assessments2

 

Point-of-Care Assessment Advantages

  • Moving lab equipment to the point of care (PoC) increases time efficiency by 40%3
  • Studies show a 32% reduction in unnecessary CTPA when gas exchange data is added to the PE workup4
  • "Oxygen Deficit has high prognostic value with a fidelity that exceeds or matches the accuracy of the best predictive tools for respiratory failure in the published literature"

 

Sources

1  https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2828189
2 https://pubmed.ncbi.nlm.nih.gov/34671670/, https://bmjopenrespres.bmj.com/content/11/1/e002250
3 http://dx.doi.org/10.1016/j.chest.2017.02.003 

4 https://pubmed.ncbi.nlm.nih.gov/35976533
5 https://pubmed.ncbi.nlm.nih.gov/40869707/

AGM100: PoC Innovation newly reimbursable under dedicated CPT® code with Ambulatory Procedure classification.

Visualizing Gas Exchange with the AGM100

The AGM100® instantly detects respiratory impairment severity and contributing sources, visualizing the gas-exchange interface between lung function and heart function. It quantifies oxygen and carbon dioxide dynamics in one non-invasive test. All measurements shown are available and displayed instantly.

MediPines AGM100

Advancements Rooted in Respiratory Physiology

Oxygenation, Ventilation, and Gas Exchange Measurements in One Breathing Session

Essential Clinical Insights, Non-Invasively Delivered Instantly at the Point-of-Care

background-video-mp

Pulmonary gas exchange is critical for our health- as shown in the lungs' tiny alveoli. Here, oxygen is absorbed into the blood, and carbon dioxide is released to be exhaled. This natural process of gas movement in the body, called diffusion,  occurs in 500 million alveoli and ensures our blood is oxygen-rich for circulation.

The AGM100 technology leverages this principle, monitoring gas levels directly with advanced sensors combined with computational means to enhance precision to aid in assessing patients' respiratory and cardiovascular health.  Vital clinical information, such as blood oxygenation, ventilation and gas exchange, that traditionally required time-consuming invasive procedures is now available at the point-of-care with the AGM100. 

  • Gas Exchange

    Assessing respiratory impairment in patients is a critical aspect of clinical management. Traditionally, the Riley method (A-a gradient) has been the gold standard measure for gas exchange efficiency, but this approach...

    Read more


  • Clinical Accuracy

    Clinicians know that unlike other tests, the AGM100 provides accurate measurements of gas exchange impairment to differentiate healthy and sick patients...

    Read more


     

  • Operational Efficiency

    Patients in respiratory distress require immediate medical attention. The ability to quickly identify hypoxemia is crucial...

    Read more

Industry Coverage

who logo

Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured...

DR MARIÂNGELA SIMÃO

WHO Assistant Director General

 

la business journal logo

“The AGM100 is already playing a crucial role in respiratory assessment and treatment in a quickly growing number of hospitals across the nation."

LOS ANGELES BUSINESS JOURNAL

pictures-11

“These winners represent some of the most promising emerging medical device innovations in the diagnosis, treatment, and care of children affected..."

PAUL GRAND

CEO of MedTech Innovator

News